Identification of Secreted Copper-Binding Peptides Associated with Virulence in Pathogenic Pseudomonas and Bordetella
ACS Infectious Diseases · 28.10.2026
DOI: 10.1021/acsinfecdis.6c00653 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 28.10.2026. Verfasst von Olivia M Steiner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina27514, United States. Hauptthemen laut MEDLINE: Copper, Peptides, Pseudomonas aeruginosa, Bacterial Proteins. Die Arbeit nennt 38 Literaturangaben. Gefördert von: David and Lucile Packard Foundation, NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Peptides that contain 5-thiooxazole post-translational modifications have recently been identified from various bacteria and implicated in copper homeostasis and virulence. However, knowledge of their copper-binding affinities is limited, and their roles in virulence are not well understood. In this work, we discovered three new 5-thiooxazole-containing peptides from two opportunistic human pathogens, Pseudomonas aeruginosa and Bordetella bronchiseptica. We heterologously produced and structurally characterized two different peptides that originate from P. aeruginosa, pseudomonin and pseudomonin-efh, the latter of which also contains two EF-hand domains for calcium binding. We show that 5-thiooxazole modification in both peptides enables strong Cu(I) binding at 10–16–10–17 M affinity and weaker Cu(II) binding at 10–7 M affinity. Pseudomonin-efh undergoes calcium-dependent changes of overall secondary structure that are negated by copper. Genetic studies revealed the 5-thiooxazole modification of pseudomonin-efh is required for calcium-dependent virulence regulation in a lettuce infection model for P. aeruginosa. Further, we identified and characterized a related 5-thiooxazole-containing peptide, bordetellin, secreted by its native producer, B. bronchiseptica, in the virulent phase. Our work demonstrates a strong preference for Cu(I) binding by 5-thiooxazole-containing peptides and uncovers a role of these peptides in Ca/Cu-dependent virulence regulation. Identifying 5-thiooxazole-containing peptides from pathogenic bacteria and detecting their secretion in the native producer is a critical step toward understanding the functions of these peptides in virulence and pathogen–host interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina27514, United States.
- Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, North Carolina27858, United States.
ORCID-Profile: Olivia M Steiner, Bo Li
Förderung
- David and Lucile Packard Foundation
- NCI NIH HHS
- NIGMS NIH HHS
- National Science Foundation Graduate Research Fellowship Program
- National Institutes of Health (NIH)
- National Cancer Institute
- National Institute of General Medical Sciences
- National Institute of Health
Zitieren
APA
Steiner, O. M., Turek-Herman, J. R., Andrews-Wilson, J. A., Furie, A. J., Johnson, R. M., & Li, B. (2026). Identification of Secreted Copper-Binding Peptides Associated with Virulence in Pathogenic Pseudomonas and Bordetella. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.6c00653
Vancouver
Steiner OM, Turek-Herman JR, Andrews-Wilson JA, Furie AJ, Johnson RM, Li B. Identification of Secreted Copper-Binding Peptides Associated with Virulence in Pathogenic Pseudomonas and Bordetella. ACS Infectious Diseases. 2026. doi:10.1021/acsinfecdis.6c00653
BibTeX
@article{Steiner2026,
author = {Steiner, Olivia M and Turek-Herman, Joshua R and Andrews-Wilson, Jordyn A and Furie, Alyssa J and Johnson, Richard M and Li, Bo},
title = {Identification of Secreted Copper-Binding Peptides Associated with Virulence in Pathogenic Pseudomonas and Bordetella},
journal = {ACS Infectious Diseases},
year = {2026},
doi = {10.1021/acsinfecdis.6c00653}
}
EUVIMED